These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6804061)

  • 1. [Intrathecal injection of harringtonine and homoharringtonine in treating central nervous system leukemia--clinical analysis of 26 cases (author's transl)].
    Hou CH; Zhang ZY
    Zhonghua Yi Xue Za Zhi; 1981 Sep; 61(9):530-2. PubMed ID: 6804061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical analysis of the therapeutic effect of semisynthetic harringtonine in treating 55 cases of nonlymphocytic leukemia (author's transl)].
    Zhang ZY
    Zhonghua Nei Ke Za Zhi; 1981 Nov; 20(11):667-9. PubMed ID: 7341094
    [No Abstract]   [Full Text] [Related]  

  • 3. Harringtonine in acute leukemias. Clinical analysis of 31 cases.
    Chin Med J (Engl); 1977 Sep; 3(5):319-24. PubMed ID: 411635
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase I trial of homoharringtonine in children with refractory leukemia.
    Tan CT; Luks E; Bacha DM; Steinherz P; Steinherz L; Mondora A
    Cancer Treat Rep; 1987 Dec; 71(12):1245-8. PubMed ID: 3480043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined harringtonine or homoharringtonine chemotherapy for acute nonlymphocytic leukemia in 25 children.
    Li YH; Guo SF; Zhou FY; Xu SZ; Zhang HL
    Chin Med J (Engl); 1983 Apr; 96(4):303-5. PubMed ID: 6413148
    [No Abstract]   [Full Text] [Related]  

  • 6. Cephalotaxine esters in the treatment of acute leukemia. A preliminary clinical assessment.
    Chin Med J (Engl); 1976 Jul; 2(4):263-72. PubMed ID: 825360
    [No Abstract]   [Full Text] [Related]  

  • 7. Curative effect of harringtonine semisynthetic harringtonine and HOAP on nonlymphocytic leukemias. Analysis of 304 cases.
    Zhang ZY; Hou CH; Zhu YF; You XY; Li JL; Fu Z
    Chin Med J (Engl); 1987 Jul; 100(7):565-8. PubMed ID: 3123163
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor activities of harringtonine and homoharringtonine, cephalotaxus alkaloids which are active principles from plant by intraperitoneal and oral administration.
    Takeda S; Yajima N; Kitazato K; Unemi N
    J Pharmacobiodyn; 1982 Oct; 5(10):841-7. PubMed ID: 7161711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemical, pharmacological and clinical studies on the antitumor active principle of Cephalotaxus hainanensis Li (author's transl)].
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):176-82. PubMed ID: 298845
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cells.
    Jiang TL; Liu RH; Salmon SE
    Invest New Drugs; 1983; 1(1):21-5. PubMed ID: 6678854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A preliminary therapeutic analysis of 82 cases of chronic granulocytic leukemia treated with harringtonine].
    Zhang ZY; Hou CH; Zhu YF
    Zhonghua Nei Ke Za Zhi; 1986 Mar; 25(3):156-7, 190. PubMed ID: 3461929
    [No Abstract]   [Full Text] [Related]  

  • 12. Homoharringtonine as a new antileukemic agent.
    Ohnuma T; Holland JF
    J Clin Oncol; 1985 May; 3(5):604-6. PubMed ID: 3889228
    [No Abstract]   [Full Text] [Related]  

  • 13. Homoharringtonine--perspectives on an active new natural product.
    O'Dwyer PJ; King SA; Hoth DF; Suffness M; Leyland-Jones B
    J Clin Oncol; 1986 Oct; 4(10):1563-8. PubMed ID: 3531426
    [No Abstract]   [Full Text] [Related]  

  • 14. Homoharringtonine: a phase I evaluation.
    Stewart JA; Krakoff IH
    Invest New Drugs; 1985; 3(3):279-86. PubMed ID: 4066221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cephalotaxine esters: antileukemic advance or therapeutic failure?
    Grem JL; Cheson BD; King SA; Leyland-Jones B; Suffness M
    J Natl Cancer Inst; 1988 Sep; 80(14):1095-103. PubMed ID: 3045335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical investigation of homoharringtonine.
    Legha SS; Keating M; Picket S; Ajani JA; Ewer M; Bodey GP
    Cancer Treat Rep; 1984 Sep; 68(9):1085-91. PubMed ID: 6478448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent Iv homoharringtonine for the treatment of refractory epithelial carcinoma of the ovary: a phase II trial.
    Kavanagh JJ; Gershenson DM; Copeland LJ; Wharton JT; Rutledge FN; Krakoff IH
    Cancer Treat Rep; 1984 Dec; 68(12):1503-4. PubMed ID: 6542450
    [No Abstract]   [Full Text] [Related]  

  • 18. Small-dose Harringtonine induces complete remission in patients with acute promyelocytic leukemia.
    Ye JS; Wang XH; Feng GH; Liang GR; Liu ZP
    Leukemia; 1988 Jul; 2(7):427-9. PubMed ID: 3164799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic cell differentiation in vivo and in vitro: arrest of proliferation parallels the differentiation induced by the antileukemic drug Harringtonine.
    Boyd AW; Sullivan JR
    Blood; 1984 Feb; 63(2):384-92. PubMed ID: 6692041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Harringtonine in the treatment of polycythemia vera--analysis of 12 cases].
    Lu LH
    Zhonghua Nei Ke Za Zhi; 1984 Jul; 23(7):413-5, 462. PubMed ID: 6518868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.